RIDR-PI-103, ROS-activated PI3K inhibitor prodrug inhibits cell growth and impairs the PI3K/Akt pathway in BRAF and MEK inhibitor resistant BRAF-mutant melanoma cellsHima Patel,Rosalin Mishra,Adam Wier, Nazanin Mokhtarpour,Edward J. Merino,Joan T. GarrettCANCER RESEARCH（2022）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
